Melissa Bondy

About

Melissa Bondy, PhD, is the Principal Investigator of the Bondy Lab at Stanford Medicine and has been appointed chair of the Department of Epidemiology and Population Health, formerly known as the Department of Health Research and Policy. She also serves as the associate director for population sciences at the Stanford Cancer Institute, where she leads the research enterprise of the institute’s population sciences program. This program is designed to reduce the burden of cancer and improve outcomes for patients with cancer. Dr. Bondy earned her PhD in epidemiology from the University of Texas School of Public Health. Prior to joining Stanford, she spent nearly two decades at Baylor College of Medicine. In 2001, she became director of the Childhood Cancer Epidemiology and Prevention Center, a joint center of Baylor College of Medicine, MD Anderson Cancer Center, and Texas Children’s Hospital. Ten years later, she assumed the role of associate director of Cancer Prevention and Population Sciences at Baylor College of Medicine’s Dan L. Duncan Cancer Center, focusing much of her research on understanding heredity patterns and genetic susceptibilities in brain and breast cancer.

Research topics

• Genetics
• Biology
• Medicine
• Cancer research
• Nursing
• Oncology
• Statistics
• Family medicine

Selected publications

• US Public Concerns About the COVID-19 Pandemic From Results of a Survey Given via Social Media

  JAMA Internal Medicine · 2020 · 187 citations

  increasing from 18.6% to 23.6% of total expenditures and accounting for 28.6% of the increased spending. Specialty care was the third largest category, accounting for 17.9% of the increase in spending.

  DOI

• <i>POT1</i> mutation spectrum in tumour types commonly diagnosed among <i>POT1</i>-associated hereditary cancer syndrome families

  Journal of Medical Genetics · 2020 · 46 citations

  BACKGROUND: mutations to development of other sporadic cancers is largely unexplored. METHODS: mutation frequency and tumour type in 62 368 tumours undergoing next-generation sequencing. RESULTS: mutation frequency versus other tumours (p=0.67). CONCLUSIONS: deficiency activate a telomere-lengthening mechanism that is uncommon in gliomagenesis.

  DOI

• Susan G. Komen’s ShareForCures: a patient-engaged, nationwide breast cancer research registry

  JNCI Journal of the National Cancer Institute · 2025-12-06 · 1 citations

  articleOpen accessSenior author

  ShareForCures® is a newly launched and growing dataset, crowd-sourced from participants, that comprises self-reported, clinical, and genomics data. ShareForCures seeks to advance breast cancer research by expanding patient participation in research therefore accelerating discoveries. It is designed to 1) provide opportunities for individuals who have or had breast cancer to participate in research; 2) create a longitudinal cohort that represents the diversity of individuals diagnosed with breast…

  PublisherOA PDFDOI

• Gestational diabetes and subsequent risk of type 2 diabetes and metabolic dysfunction-associated steatotic liver disease in a commercially insured U.S. Pregnancy cohort

  Diabetes Research and Clinical Practice · 2026-04-03

  articleOpen access

  AIMS: Gestational diabetes mellitus (GDM) is a common pregnancy complication and marker of subsequent metabolic risk. Whether GDM increases metabolic dysfunction-associated steatotic liver disease (MASLD) directly or mainly through progression to type 2 diabetes (T2D) remains unclear. METHODS: MarketScan® Commercial Database (2007-2023), we assembled a retrospective cohort of females aged 12-55 years with ≥ 20 gestational weeks and continuous enrollment from 90 days pre-pregnancy through ≥ 1 yea…

  PublisherOA PDFDOI

• Ambient air pollution and survival among Black women with epithelial ovarian cancer across diverse geographical regions of the United States

  Environmental Epidemiology · 2025-10-17

  articleOpen access

  Background: Ovarian cancer is a leading cause of gynecologic cancer mortality, with Black women experiencing 5-year survival rates of only 41%. Disproportionate air pollution exposure may impact survival. We evaluated associations of fine particulate matter (PM 2.5 ) and nitrogen dioxide (NO 2 ) exposure with survival among Black women with epithelial ovarian cancer using data from the California Cancer Registry (CCR, n = 540) and the multi-state African American Cancer Epidemiology Study (AACES…

  PublisherDOI

Recent grants

• NIH Grant R01CA139020

  NIH · $16.0M · 2017

• Baylor College of Medicine Cancer Center - Cancer Center Support Grant

  NIH · $60.1M · 2007–2030

• Discovery, Biology and Risk of Inherited Variants in Glioma

  NIH · $4.7M · 2020–2026

Frequent coauthors

• Siegal Sadetzki

  Tel Aviv University

  4688 shared

• Christoffer Johansen

  Rigshospitalet

  3708 shared

• Beatrice Melin

  Umeå University

  3691 shared

• Elizabeth B. Claus

  Yale University

  3684 shared

• Åke Borg

  Lund University

  3456 shared

• Jill S. Barnholtz‐Sloan

  2727 shared

• Joellen M. Schildkraut

  Emory University

  2715 shared

• Margaret Wrensch

  University of California, San Francisco

  2676 shared

Awards & honors

• Visiting Scholar Award from the NCI Division of Cancer Epide…

Similar researchers at Stanford University

• Brian Batemanh-105
• Erik Brynjolfssonh-94
• Jud Campbellh-78